Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Respiratory Syncytial Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05110261
What this trial is testing

Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China

Who this might be right for
Lower Respiratory Tract Infection
AstraZeneca 800
Testing effectiveness (Phase 2)Study completedNCT06170242
What this trial is testing

A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 142
Not applicableStudy completedNCT00384462
What this trial is testing

Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 346
Early research (Phase 1)Study completedNCT05642403
What this trial is testing

XW001 in Healthy Adult Subjects

Who this might be right for
Respiratory Syncytial Virus Infections
Hangzhou Sciwind Biosciences Co., Ltd. 81
Not applicableLooking for participantsNCT06881953
What this trial is testing

Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France

Who this might be right for
RSV Infection
Assistance Publique - Hôpitaux de Paris 400
Early research (Phase 1)Study completedNCT00192465
What this trial is testing

Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 30
Testing effectiveness (Phase 2)Study completedNCT05630573
What this trial is testing

TNM001 in Chinese Healthy Preterm and Term Infants

Who this might be right for
Respiratory Syncytial Virus Infections
Zhuhai Trinomab Pharmaceutical Co., Ltd. 31
Large-scale testing (Phase 3)Ended earlyNCT05238025
What this trial is testing

MVA-BN-RSV Vaccine Trial

Who this might be right for
Respiratory Syncytial Virus Infections
Bavarian Nordic 20,419
Large-scale testing (Phase 3)Study completedNCT06710925
What this trial is testing

A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants

Who this might be right for
Respiratory Syncytial Virus Infections
Zhuhai Trinomab Pharmaceutical Co., Ltd. 315
Not applicableStudy completedNCT05572658
What this trial is testing

Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 10,994
Early research (Phase 1)Study completedNCT01909843
What this trial is testing

ALX-0171 Safety Study in Adults With Hyperresponsive Airways

Who this might be right for
Respiratory Syncytial Virus Infection
Ablynx, a Sanofi company 24
Large-scale testing (Phase 3)Study completedNCT05070546
What this trial is testing

An Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Who this might be right for
Respiratory Syncytial Virus Infection Prevention
Janssen Vaccines & Prevention B.V. 1,124
Not applicableStudy completedNCT04623047
What this trial is testing

Infection Watch Study

Who this might be right for
COVID-19 Respiratory InfectionRespiratory Syncytial Virus InfectionsRhinoviral Infections+1 more
Duke University 10,034
Testing effectiveness (Phase 2)Looking for participantsNCT07734649
What this trial is testing

Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older

Who this might be right for
Respiratory Syncytial Virus ImmunizationHuman Metapneumovirus ImmunizationHealthy Volunteers
Sanofi 2,400
Not applicableStudy completedNCT01077271
What this trial is testing

Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA

Who this might be right for
Premature Infants
Abbott 124
Early research (Phase 1)Study completedNCT04065698
What this trial is testing

Pharmacokinetics and Safety of RV521 Formulations

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 9
Not applicableStudy completedNCT03919591
What this trial is testing

RSV Study in Adults 60 to 75 Years of Age

Who this might be right for
RSV Infection
Hvivo 24
Large-scale testing (Phase 3)Study completedNCT05966090
What this trial is testing

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

Who this might be right for
Respiratory Syncytial VirusesRespiratory Syncytial Virus Infections
GlaxoSmithKline 530
Early research (Phase 1)Study completedNCT03755778
What this trial is testing

Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 72
Early research (Phase 1)UnknownNCT02958540
What this trial is testing

Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine

Who this might be right for
Respiratory Syncytial Viral Infections
Mucosis BV 48
Next Page